-
Mashup Score: 2Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers - 3 month(s) ago
Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian.
Source: www.curetoday.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers - 3 month(s) ago
Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian.
Source: www.curetoday.comCategories: General Medicine NewsTweet-
RT @cure_today: Clinical Trials Enhance Care for Advanced #GastrointestinalCancers @MPishvaian @hopkinskimmel https://t.co/oTSJ2DV8Nb
-
-
Mashup Score: 4Association Between CLDN18 and MUC1 Could Drive Novel Targeted Therapy Options in GI Cancers - 3 month(s) ago
Aditya Shreenivas, MD, MS, discusses the association between Claudin 18 and MUC1 biomarkers and ongoing targeted therapy challenges.
Source: www.onclive.comCategories: General Medicine NewsTweet-
Although there are established associations between CLDN18 and MUC1, there isn’t a treatment available that can target both biomarkers in #GastrointestinalCancers. @AdityaSunavs @cityofhope @ASCO Read more: https://t.co/Uy1ohTyGQO https://t.co/0f2aNV8GW3
-
-
Mashup Score: 16Perioperative pembrolizumab plus chemotherapy in locally-advanced gastric/GEJ cancer - 10 month(s) ago
Kohei Shitara
Source: oncologypro.esmo.orgCategories: General Medicine News, Oncologists1Tweet-
📣 For ESMO members: Breaking Science in #GastrointestinalCancers. Kohei Shitara talks about the Perioperative pembrolizumab plus chemotherapy in locally-advanced gastric/GEJ cancer. Full interview available now on OncologyPRO: 🔗https://t.co/VY3p5gYlj1 https://t.co/pJLgjWmseL
-
-
Mashup Score: 15Neoadjuvant regorafenib, nivolumab and short-course radiotherapy for stage II-III rectal cancer - 10 month(s) ago
Francesco Sclafani
Source: oncologypro.esmo.orgCategories: General Medicine News, Oncologists1Tweet-
For ESMO members: Breaking Science in #GastrointestinalCancers. Francesco Sclafani shares insights on his presentation about Neoadjuvant regorafenib, nivolumab and short-course radiotherapy for stage II-III rectal cancer Full interview on OncologyPRO: 🔗https://t.co/tLldPWVeEZ https://t.co/OWdYu3VAdN
-
-
Mashup Score: 5Gastrointestinal Cancer Videos - 11 month(s) agoSource: oncologypro.esmo.orgCategories: General Medicine News, Oncologists1Tweet
-
📣 Dive into our "Breaking Science in Gastrointestinal Cancers" Series, now available on OncologyPRO. Join 7 leading experts as they deliver interviews and provide summaries of groundbreaking study results from ESMO #GastrointestinalCancers 2024. 🔗 https://t.co/Pk0VvQeWTb https://t.co/nhXs19M7il
-
-
Mashup Score: 9Pembrolizumab combo with XELOX and bev for pMMR/MSS mCRC and high immune infiltrate - 12 month(s) ago
David Tougeron
Source: oncologypro.esmo.orgCategories: General Medicine News, Oncologists1Tweet-
📣For ESMO members: Breaking Science in #GastrointestinalCancers. David Tougeron discusses Pembrolizumab combo with XELOX and bev for pMMR/MSS mCRC and high immune infiltrate. 👉 Discover this video and more in the series on OncologyPRO now. 🔗 https://t.co/QB2bnVEgaj https://t.co/1q5tduQo6Z
-
-
Mashup Score: 4Switch maintenance with ramucirumab plus paclitaxel in advanced HER2-negative gastric/GEJ cancer - 12 month(s) ago
Giovanni Randon
Source: oncologypro.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet-
📣 For ESMO members: Breaking Science in #GastrointestinalCancers Giovanni Randon presents Switch maintenance with ramucirumab plus paclitaxel in advanced HER2-negative gastric/GEJ cancer 👉Discover this video and more in the series on OncologyPRO now. 🔗 https://t.co/iVrHKzk5yu https://t.co/2QzWSx7RZS
-
-
Mashup Score: 18Perioperative pembrolizumab plus chemotherapy in locally-advanced gastric/GEJ cancer - 12 month(s) ago
Kohei Shitara
Source: oncologypro.esmo.orgCategories: General Medicine News, Oncologists1Tweet-
📣For ESMO members: Breaking Science in #GastrointestinalCancers: Kohei Shitara talks about the Perioperative pembrolizumab plus chemotherapy in locally-advanced gastric/GEJ cancer. 👉 Don't miss this video and others from the series on OncologyPRO. 🔗 https://t.co/kZWr1aIoWb https://t.co/Wnmkq9ibHb
-
-
Mashup Score: 6Sequences of regorafenib and trifluridine/tipiracil after failure of standard therapies for mCRC - 12 month(s) ago
Michel P. Ducreux
Source: oncologypro.esmo.orgCategories: General Medicine News, Oncologists1Tweet-
📣 ESMO members: Breaking Science in #GastrointestinalCancers. Michel P. Ducreux presents his findings on Sequences of regorafenib and trifluridine/tipiracil after failure of standard therapies for mCRC. 👉 Watch this video on OncologyPRO now. 🔗 https://t.co/6aA8OBZeOM https://t.co/ZcvbSoNiPh
-
RT @cure_today: Clinical Trials Enhance Care for Advanced #GastrointestinalCancers @MPishvaian @hopkinskimmel https://t.co/oTSJ2DV8Nb